Q4 2025 Holdings
Filed 2026-02-09 | 74 holdings | $124.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $10.1M | 589,005 | 8.1% |
| Contineum Therapeutics(CTNM) | CL A | 21217B100 | $9.2M | 800,787 | 7.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.8M | 7,276 | 6.3% |
| Shoulder Innovations(SI) | COMMON STOCK | 82537J108 | $7.0M | 492,435 | 5.6% |
| Unitedhealth GRP Inc(UNH) | COM | 91324P102 | $4.5M | 13,595 | 3.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $4.3M | 13,070 | 3.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $4.2M | 20,300 | 3.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.8M | 16,800 | 3.1% |
| Vertex Pharma(VRTX) | COM | 92532F100 | $3.6M | 8,005 | 2.9% |
| Abbott Labs(ABT) | COM | 002824100 | $2.9M | 23,498 | 2.4% |
| Regeneron Pharmctcls(REGN) | COM | 75886F107 | $2.9M | 3,715 | 2.3% |
| Intuitive Surgic Inc(ISRG) | COM NEW | 46120E602 | $2.7M | 4,850 | 2.2% |
| Boston Scientific(BSX) | COM | 101137107 | $2.6M | 27,626 | 2.1% |
| Argenx SE SPN ADR(ARGX) | SP ADR | 04016X101 | $2.4M | 2,894 | 2.0% |
| Danaher Corp(DHR) | COM | 235851102 | $2.4M | 10,575 | 1.9% |
| Stryker Corp(SYK) | COM | 863667101 | $2.3M | 6,550 | 1.8% |
| Thermo Fisher Scientific(TMO) | COM | 883556102 | $2.3M | 3,900 | 1.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $2.3M | 21,400 | 1.8% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.2M | 17,885 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.9M | 11,182 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.9M | 28,700 | 1.5% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $1.9M | 36,858 | 1.5% |
| Structure Therapeutics(GPCR) | SP ADR | 86366E106 | $1.7M | 23,872 | 1.3% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $1.6M | 17,218 | 1.3% |
| Edwards Lifescience(EW) | COM | 28176E108 | $1.5M | 17,250 | 1.2% |
| Astrazeneca(AZN) | SP ADR | 046353108 | $1.4M | 15,232 | 1.1% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $1.4M | 79,625 | 1.1% |
| Arcus Biosciences(RCUS) | COM | 03969F109 | $1.4M | 56,945 | 1.1% |
| Syndax Pharmaceuticals(SNDX) | COM | 87164F105 | $1.3M | 61,200 | 1.0% |
| Tarsus Pharmaceutical(TARS) | COM | 87650L103 | $1.2M | 14,740 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.2M | 2,990 | 1.0% |
| Rapport Therapeutics(RAPP) | COM | 75383L102 | $1.2M | 38,925 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.2M | 32,685 | 0.9% |
| Mineralys Therapeutics(MLYS) | COM | 603170101 | $1.1M | 31,625 | 0.9% |
| Trevi Therapeutic Inc(TRVI) | COM | 89532M101 | $1.1M | 84,255 | 0.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $984.0K | 45,347 | 0.8% |
| Tectonic Therapeutics(TECX) | COM | 878972108 | $881.4K | 42,255 | 0.7% |
| Ventyx Biosciences(VTYX) | COM | 92332V107 | $875.4K | 96,945 | 0.7% |
| Bridgebio Pharma(BBIO) | COM | 10806X102 | $854.4K | 11,170 | 0.7% |
| United Therapeutics(UTHR) | COM | 91307C102 | $839.5K | 1,723 | 0.7% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $814.3K | 678,574 | 0.7% |
| Beone Medicines LTD(ONC) | SP ADR | 07725L102 | $809.7K | 2,665 | 0.6% |
| Radnet Inc(RDNT) | COM | 750491102 | $784.9K | 11,000 | 0.6% |
| Arrivent Biopharma(AVBP) | COM | 04272N102 | $769.7K | 38,255 | 0.6% |
| Uniqure N.V.(QURE) | SHS | N90064101 | $731.9K | 30,585 | 0.6% |
| Ascendis Pharma(ASND) | SP ADR | 04351P101 | $693.9K | 3,254 | 0.6% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $680.0K | 42,500 | 0.5% |
| Pfizer Inc(PFE) | COM | 717081103 | $676.0K | 27,150 | 0.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $664.1K | 7,200 | 0.5% |
| Ionis Pharmaceutical(IONS) | COM | 462222100 | $661.8K | 8,365 | 0.5% |